Ultragenyx bags first gene therapy approval as previously rejected Sanfilippo asset awaits decision
Ultragenyx bags first gene therapy approval as previously rejected Sanfilippo asset awaits decision
Ultragenyx Pharmaceutical
RARE $25.83 USD
Biopharmaceutical company
Company Info
Recent News
Ultragenyx, after FDA speed bump, lands 1st gene therapy nod
Ultragenyx, after FDA speed bump, lands 1st gene therapy nod
Ultragenyx Gene Therapy Becomes First FDA-Approved Treatment for Ultra-Rare Disease
Ultragenyx Gene Therapy Becomes First FDA-Approved Treatment for Ultra-Rare Disease